NCT03905733

Brief Summary

The aim of this study is to evaluate the effect of high-flow nasal cannula oxygen administration on maintenance of oxygenation and removal of carbon dioxide during apnoeic period in pediatric patients undergoing general anesthesia with rigid bronchoscopy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 2, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 5, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

April 5, 2019

Status Verified

April 1, 2019

Enrollment Period

2 years

First QC Date

April 2, 2019

Last Update Submit

April 3, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Hypoxia occurs the first time

    The time taken to reach the point at which peripheral oxygen saturation fell below 90 for the first time immediately after the onset of apnea

    The time taken to reach the point at which peripheral oxygen saturation fell below 90% for the first time immediately after the onset of apnea intraoperatively.

  • the lowest oxygen saturation

    the lowest value of oxygen saturation measured percutaneously at extremity.

    apnea period during the rigidbroscopic procedure/surgery

  • Occurence of hypoxic event

    Occurence of hypoxic event: Presence or absence of hypoxia(peripheral oxygen saturation fell below 90% ) during rigid bronchoscopy

    apnea period during the rigidbroscopic procedure/surgery

Secondary Outcomes (2)

  • End-tidal carbon dioxide partial pressure

    end-tidal CO2 partial pressure after 3 consecutive breaths after intubation or insertion of laryngeal mask following end of apnea during intraoperative period.

  • Arterial oxygen / carbon dioxide partial pressure

    shortly before start of apnea (within 30 seconds) and shortly after end of apnea (within 30 seconds)

Study Arms (1)

general anesthesia with rigid bronchoscopy

Patients 7 years or younger who undergo general anesthesia with rigid bronchoscopy

Device: Optiflow

Interventions

OptiflowDEVICE

supply of oxygen at 2 L / min/ kg through Optiflow

general anesthesia with rigid bronchoscopy

Eligibility Criteria

AgeUp to 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients 7 years or younger who undergo general anesthesia with rigid bronchoscopy

You may qualify if:

  • \. Patients undergoing general anesthesia with stent placement or bougination, biopsy or removal of a foreign body or a mass through a rigid bronchoscope
  • \. Patients aged 7 or younger who meet American Society of Anesthesiologists (ASA) physical class 2-4

You may not qualify if:

  • \. Patients undergoing extracorporeal membrane oxygenation (ECMO)
  • \. Patients with active nasal bleeding), severe nasal obstruction, recent nasal trauma of surgery
  • \. Patients with current maxillofacial trauma or basal skull fracture
  • \. Patients with active nasal bleeding), severe nasal obstruction, recent nasal trauma of surgery
  • \. Extremely low birth weight infant and premature infant less than 28 weeks gestation age
  • \. Patients who had previously undergone rigid bronchoscopy / surgery
  • \. If the parent of subject includes a person who can not read the written consent (eg, illiterate, foreigner, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine

Seoul, South Korea

RECRUITING

MeSH Terms

Conditions

Foreign BodiesNeoplasmsTracheal Stenosis

Condition Hierarchy (Ancestors)

Wounds and InjuriesTracheal DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 2, 2019

First Posted

April 5, 2019

Study Start

April 1, 2019

Primary Completion

April 1, 2021

Study Completion

April 1, 2021

Last Updated

April 5, 2019

Record last verified: 2019-04

Locations